Drug Trial Radar · NCT04205812
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
583
Actual
Start
Sep 11, 2020
Primary completion
Dec 15, 2023
Study completion May 28, 2026
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Dec 19, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC).
Conditions
- Metastatic Squamous Non-Small Cell Lung Cancer
- Metastatic Nonsquamous Non-Small Cell Lung Cancer
Interventions
RetifanlimabDrug
INCMGA00012 administered intravenously every 3 weeks on Day 1 of each cycle for up to 35 cycles.
PlaceboDrug
Placebo administered intravenously every 3 weeks on Day 1 of each cycle for up to 35 cycles.
PemetrexedDrug
Pemetrexed administered intravenously every 3 weeks on Day 1 of each cycle.
CisplatinDrug
Cisplatin administered intravenously every 3 weeks on Day 1 of each cycle for 4 cycles.
CarboplatinDrug
Carboplatin administered intravenously every 3 weeks on Day 1 of each cycle for 4 cycles.
PaclitaxelDrug
Paclitaxel administered intravenously every 3 weeks on Day 1 of each cycle for 4 cycles.
nab-PaclitaxelDrug
nab-Paclitaxel administered intravenously every 3 weeks on Days 1, 8, and 15 of each cycle for 4 cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: up to 39.1 months
Locations
140 sites in 17 countries. Site status is shown where the registry gives one.
Pacific Cancer Medical Center
Anaheim, California
Innovative Clinical Research Institute
Whittier, California
Reading Hospital and Medical Center
Reading, Pennsylvania
Fundacao Pio Xii Hospital de Cancer de Barretos
Barretos, Brazil
Incan - Instituto Do Cancer - Hospital Pompeia
Caxias do Sul, Brazil
Centro Regional Integrado de Oncologia
Fortaleza, Brazil
Oncosite - Centro de Pesquisa Clinica E Oncologia
Ijuí, Brazil
Clinica de Neoplasias Litoral Ltda
Itajaí, Brazil
Hospital Do Cancer de Londrina
Londrina, Brazil
Instituto Mederi de Pesquisa E Saude
Passo Fundo, Brazil
Hgb - Hospital Giovanni Battista - Mae de Deus Center
Porto Alegre, Brazil
Inca - Instituto Nacional de Cancer
Rio de Janeiro, Brazil
Sao Camilo Oncologia
S?O Paulo, Brazil
Cepho - Centro de Estudos E Pesquisas de Hematologia E Oncologia
Santo André, Brazil
Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto
São José, Brazil
Mc Women'S Health-Nadezhda Eood
Sofia, Bulgaria
Acibadem Cityclinica Mhat Tokuda
Sofia, Bulgaria
Umhat Sv. Ivan Rilski Ead
Sofia, Bulgaria
Mhat Serdika Eood
Sofia, Bulgaria
Multiprofile Hospital For Active Treatment Central Onco Hospital Ood
Sofia, Bulgaria
Shatod Dr Marko Marko - Varna Ltd
Varna, Bulgaria
Hunan Cancer Hospital
Changsha, China
The First Affiliated Hospital Sun Yat-Sen University
Guangzhou, China
Sir Run Run Shaw Hospital Zhejiang University School of Medicine
Hangzhou, China
Hangzhou Cancer Hospital
Hangzhou, China
The First Affiliated Hospital of Zhejiang University
Hangzhou, China
Zhejiang Cancer Hospital
Hangzhou, China
Harbin Medical University Cancer Hospital
Harbin, China
University of Science and Technology of China-First Affiliated Hospital (Anhui Provincial Hospital)
Hefei, China
The Second Hospital of Anhui Medical University
Hefei, China
Jinan Central Hospital
Jinan, China
Linyi Cancer Hospital
Linyi, China
The Second Affiliated Hospital of Nanchang University
Nanchang, China
The First Affiliated Hospital of Guangxi Medical University
Nanning, China
Shanghai Chest Hospital
Shanghai, China
General Hospital of Tianjin
Tianjing, China
The Affiliated Cancer Hospital of Xinjiang Medical University
Ürümqi, China
Henan Cancer Hostipal
Zhengzhou, China
Henan Provincial Peoples Hospital
Zhengzhou, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Showing 40 of 140 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.